CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study
Authors
Agata Pisano
AL Cheng
+53 more
AL Hagemeister
Alberto D’Agostino
Antonietta Sabia
Antonio Febbraro
AX Zhu
Bruno Vincenzi
CH Takimoto
Clementina Savastano
D Dimitroulopoulos
D Strumberg
DN Samonakis
DN Samonakis
E Kaplan
E Kouroumalis
Elena Capasso
G Becker
Giovannella Palmieri
GK Abou-Alfa
Gregorio Cennamo
Guido Piai
H Minami
J Cebon
J Furuse
JC Reubi
JM Llovet
JM Llovet
JM Llovet
JT Siveke
L Buscail
L Montella
Liliana Montella
Luciano Tarantino
Luigi Maiorino
M Caraglia
M Raderer
M Zhao
Maddalena Bianco
MB Thomas
MB Thomas
Michele Caraglia
P Therasse
PA Philip
R Addeo
R Simon
Raffaele Addeo
Rosanna Mamone
Rosario Guarrasi
Salvatore Del Prete
SJ Faivre
T Yau
TWT Leung
Vincenzo Faiola
Vincenzo Montesarchio
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 05/06/2019